Results 21 to 30 of about 709,328 (257)

Biases of Drug–Target Interaction Network Data [PDF]

open access: yes, 2014
Network based prediction of interaction between drug compounds and target proteins is a core step in the drug discovery process. The availability of drug—target interaction data has boosted the development of machine learning methods for the in silico prediction of drug—target interactions.
Laarhoven, T. van, Marchiori, E.
openaire   +2 more sources

Drug-target interaction prediction using semi-bipartite graph model and deep learning

open access: yesBMC Bioinformatics, 2020
Background Identifying drug-target interaction is a key element in drug discovery. In silico prediction of drug-target interaction can speed up the process of identifying unknown interactions between drugs and target proteins.
Hafez Eslami Manoochehri   +1 more
doaj   +1 more source

Predicting Drug-Target Interactions for New Drug Compounds Using a Weighted Nearest Neighbor Profile. [PDF]

open access: yesPLoS ONE, 2013
In silico discovery of interactions between drug compounds and target proteins is of core importance for improving the efficiency of the laborious and costly experimental determination of drug-target interaction.
Twan van Laarhoven, Elena Marchiori
doaj   +1 more source

Drug–target interaction prediction using unifying of graph regularized nuclear norm with bilinear factorization

open access: yesBMC Bioinformatics, 2021
Background Wet-lab experiments for identification of interactions between drugs and target proteins are time-consuming, costly and labor-intensive. The use of computational prediction of drug–target interactions (DTIs), which is one of the significant ...
Ali Ghanbari Sorkhi   +3 more
doaj   +1 more source

A semi-supervised method for drug-target interaction prediction with consistency in networks. [PDF]

open access: yesPLoS ONE, 2013
Computational prediction of interactions between drugs and their target proteins is of great importance for drug discovery and design. The difficulties of developing computational methods for the prediction of such potential interactions lie in the ...
Hailin Chen, Zuping Zhang
doaj   +1 more source

A Novel Deep Neural Network Technique for Drug–Target Interaction

open access: yesPharmaceutics, 2022
Drug discovery (DD) is a time-consuming and expensive process. Thus, the industry employs strategies such as drug repositioning and drug repurposing, which allows the application of already approved drugs to treat a different disease, as occurred in the ...
Jackson G. de Souza   +2 more
doaj   +1 more source

Gaussian interaction profile kernels for predicting drug–target interaction [PDF]

open access: yesBioinformatics, 2011
Abstract Motivation: The in silico prediction of potential interactions between drugs and target proteins is of core importance for the identification of new drugs or novel targets for existing drugs. However, only a tiny portion of all drug–target pairs in current datasets are experimentally validated interactions.
Laarhoven, T.M. van   +2 more
openaire   +5 more sources

Does adding the drug–drug similarity to drug–target interaction prediction methods make a noticeable improvement in their efficiency?

open access: yesBMC Bioinformatics, 2022
Predicting drug–target interactions (DTIs) has become an important bioinformatics issue because it is one of the critical and preliminary stages of drug repositioning.
Reza Hassanzadeh   +1 more
doaj   +1 more source

Challenges and solutions in drug-target interaction prediction [PDF]

open access: yes, 2020
When a drug is developed, it is designed so that it interacts with a specific target of interest in order to achieve the desired therapeutic effect. However, it is quite common to later find that the developed drug also interacts with multiple other targets that were not intended during its development.
openaire   +2 more sources

Computational Discovery of Putative Leads for Drug Repositioning through Drug-Target Interaction Prediction. [PDF]

open access: yesPLoS Computational Biology, 2016
De novo experimental drug discovery is an expensive and time-consuming task. It requires the identification of drug-target interactions (DTIs) towards targets of biological interest, either to inhibit or enhance a specific molecular function.
Edgar D Coelho   +2 more
doaj   +1 more source

Home - About - Disclaimer - Privacy